DK525384D0 - Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat - Google Patents

Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Info

Publication number
DK525384D0
DK525384D0 DK525384A DK525384A DK525384D0 DK 525384 D0 DK525384 D0 DK 525384D0 DK 525384 A DK525384 A DK 525384A DK 525384 A DK525384 A DK 525384A DK 525384 D0 DK525384 D0 DK 525384D0
Authority
DK
Denmark
Prior art keywords
viii
preparation
inhibitor
pct
treatment
Prior art date
Application number
DK525384A
Other languages
Danish (da)
English (en)
Inventor
Ole Nordfang
Mirella Ezban Rasmussen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Priority to DK525384A priority Critical patent/DK525384D0/da
Publication of DK525384D0 publication Critical patent/DK525384D0/da
Priority to CA000494555A priority patent/CA1269042A/en
Priority to IL76929A priority patent/IL76929A/xx
Priority to AU50926/85A priority patent/AU599310B2/en
Priority to PCT/DK1985/000105 priority patent/WO1986002838A1/en
Priority to ES549115A priority patent/ES8701230A1/es
Priority to JP60505194A priority patent/JPH0713026B2/ja
Priority to AT85905784T priority patent/ATE69727T1/de
Priority to EP85905784A priority patent/EP0201574B1/de
Priority to DE8585905784T priority patent/DE3584775D1/de
Priority to US06/881,687 priority patent/US4831119A/en
Priority to DK318086A priority patent/DK165940C/da
Priority to DK199000418A priority patent/DK173863B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK525384A 1984-11-05 1984-11-05 Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat DK525384D0 (da)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DK525384A DK525384D0 (da) 1984-11-05 1984-11-05 Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
CA000494555A CA1269042A (en) 1984-11-05 1985-11-04 Preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
IL76929A IL76929A (en) 1984-11-05 1985-11-04 Preparation for the treatment of hemophilia a inhibitor patients and processes for producing such a preparation
US06/881,687 US4831119A (en) 1984-11-05 1985-11-05 Preparation for the treatment of hemophilia A inhibitor patients and a process for producing such a preparation
PCT/DK1985/000105 WO1986002838A1 (en) 1984-11-05 1985-11-05 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
AU50926/85A AU599310B2 (en) 1984-11-05 1985-11-05 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
ES549115A ES8701230A1 (es) 1984-11-05 1985-11-05 Procedimiento de producir preparaciones para tratar pacien- tes de hemofilia a inhibidores
JP60505194A JPH0713026B2 (ja) 1984-11-05 1985-11-05 血友病ａ抑制患者の治療のための製剤及び該製剤の製造方法
AT85905784T ATE69727T1 (de) 1984-11-05 1985-11-05 Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken.
EP85905784A EP0201574B1 (de) 1984-11-05 1985-11-05 Zusammensetzung zur behandlung von an hämophilia-a-inhibitor leidenden kranken
DE8585905784T DE3584775D1 (de) 1984-11-05 1985-11-05 Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
DK318086A DK165940C (da) 1984-11-05 1986-07-04 Praeparat til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadant praeparat
DK199000418A DK173863B1 (da) 1984-11-05 1990-02-16 Immunosorbent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK525384A DK525384D0 (da) 1984-11-05 1984-11-05 Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Publications (1)

Publication Number Publication Date
DK525384D0 true DK525384D0 (da) 1984-11-05

Family

ID=8140859

Family Applications (1)

Application Number Title Priority Date Filing Date
DK525384A DK525384D0 (da) 1984-11-05 1984-11-05 Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Country Status (11)

Country Link
US (1) US4831119A (de)
EP (1) EP0201574B1 (de)
JP (1) JPH0713026B2 (de)
AT (1) ATE69727T1 (de)
AU (1) AU599310B2 (de)
CA (1) CA1269042A (de)
DE (1) DE3584775D1 (de)
DK (1) DK525384D0 (de)
ES (1) ES8701230A1 (de)
IL (1) IL76929A (de)
WO (1) WO1986002838A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
EP0251843A1 (de) * 1986-06-06 1988-01-07 Transgene S.A. Verfahren zur Herstellung von Faktor VIII aus Säugerzellen
AU2473388A (en) * 1987-11-16 1989-06-22 Scripps Clinic And Research Foundation Treatment of factor viii inhibitors
WO1990015992A1 (en) * 1989-06-15 1990-12-27 Smith William I Jr Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids
DK0436717T3 (da) * 1989-08-02 2003-05-05 Mitra Medical Technology Ab System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
JP2004517950A (ja) * 2001-02-05 2004-06-17 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチド及び第ｖｉｉｉ因子ポリペプチドの組合された使用
LT1596887T (lt) * 2003-02-26 2022-04-25 Nektar Therapeutics Polimero-faktoriaus viii fragmento konjugatai
ES2333598T5 (es) * 2003-05-06 2013-09-04 Biogen Idec Hemophilia Inc Proteinas quimericas del factor de coagulacion fc para tratar la hemofilia.
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2006003183A1 (de) * 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
TWI683666B (zh) 2013-03-15 2020-02-01 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
US4406886A (en) * 1983-01-14 1983-09-27 University Patents, Inc. Purification of antihemophilia factor VIII by precipitation with zinc ions
EP0148843B2 (de) * 1983-03-21 1994-05-04 Novo Nordisk A/S Antihämophilie-faktor-viii-konzentrat und dessen herstellungsverfahren
US4649132A (en) * 1983-03-31 1987-03-10 Scripps Clinic And Research Foundation Treatment of Factor VIII inhibitors
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
FI852866L (fi) * 1984-07-27 1986-01-28 Meloy Lab Rekombinantfaktor viii-r.

Also Published As

Publication number Publication date
IL76929A (en) 1990-07-26
JPH0713026B2 (ja) 1995-02-15
DE3584775D1 (de) 1992-01-09
IL76929A0 (en) 1986-04-29
JPS62501006A (ja) 1987-04-23
ES549115A0 (es) 1986-12-01
WO1986002838A1 (en) 1986-05-22
EP0201574A1 (de) 1986-11-20
ES8701230A1 (es) 1986-12-01
US4831119A (en) 1989-05-16
EP0201574B1 (de) 1991-11-27
AU5092685A (en) 1986-06-03
ATE69727T1 (de) 1991-12-15
CA1269042A (en) 1990-05-15
AU599310B2 (en) 1990-07-19

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
DK525384D0 (da) Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
ES2174855T3 (es) Metodos diagnosticos y composiciones farmaceuticas que se basan en proteinas notch y acidos nucleicos.
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
FI96210C (fi) Plasmaproteiinien kromatograafinen erottaminen
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
AU3595489A (en) Amblyommin, a new active substance for anticoagulant therapy
DK318086A (da) Praeparat til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadant praeparat
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio
BR9711692A (pt) Promotor regulado de aço